International Society of Hypertension

ISH - Hero Image 1ISH - Hero Image 2ISH - Hero Image 3ISH - Hero Image 6ISH - Hero Image 8Suported by MedtronicISH - Hero Image 9ISH - Hero Image 14ISH - Hero Image 15ISH - Hero Image 16ISH - Hero Image 17ISH - Hero Image 18Suported by OmronISH - Hero Image 19ISH - Hero Image 20ISH - Hero Image 21ISH - Hero Image 22ISH - Hero Image 23Suported by Servier

Latest News

You are viewing articles tagged with "During 10/2017".

  • ISH New Investigator Committee delighted to co-sponsor the 2017 AHA/ASA Joint Hypertension Scientific Sessions, San Francisco, USA

    The AHA/ASA Joint Hypertension Scientific Sessions 2017 took place in San Francisco, USA in September. New this year was the successful addition of two clinically-oriented tracks to accommodate the interests of primary care physicians and clinician scientists brought in by the merger with the American Society of Hypertension. Consequently, the number of attendees was nearly double and abstract submission was up 30% this year, making for an intriguing blend of basic and clinical science in hypertension.

    Read More 30/10/2017

  • ISH Singapore New Investigator Symposium Awardees

    The ISH held a very successful New Investigator Symposium and a mentorship social event in Singapore on 6th October as part of the Asia Pacific Society of Hypertension (APSH) meeting. Attended by over 70 people from nearly 20 countries, a keynote lecture was given by Professor Mark Caulfield from Queen Mary University, London, UK.

    Read More 16/10/2017

Latest Tweets:

The ISH is positively committed to opposing discrimination against people on the grounds of gender, race, colour, nationality, religion, marital status, sexual orientation, class, age, disability, having dependants, HIV status or perceived lifestyle.